Clinical Trial Update: Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy of ustekinumab followed by abatacept for psoriasis vulgaris has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Abatacept (abatacept)
• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-26